© 2025 KNAU Arizona Public Radio
Arizona Public Radio | Your Source for NPR News
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations
Arizona Public Radio continues to integrate new audio software for both our news and classical services, which is resulting in some technical issues, including dead air, overlapping audio and other glitches. We are working to resolve these issues and appreciate your patience and continued support.

Pfizer Faces Celebrex Fallout

By Snigdha Prakash
Published December 19, 2004 at 10:00 PM MST

Pfizer is dealing with repercussions of a study linking its painkiller Celebrex to an increased risk of heart trouble. The company will stop airing its ads for the drug in response to a request from the Food and Drug Administration, which is mulling further action. Meanwhile, Pfizer's stock continued to sink on Wall Street. NPR's Snigdha Prakash reports.

Copyright 2004 NPR
NPR News
Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.